* Job Type: Officer of Administration * Bargaining Unit: * Regular/Temporary: Regular * End Date if Temporary: * Hours Per Week: 35 * Standard Work Schedule: * Building: * Salary Range: $90,000 to...
COMPANY Volastra Therapeutics, Inc. is a clinical stage oncology biotechnology company based in New York City focused on developing therapeutics that exploit chromosomal instability (CIN) as a unique vulnerability in cancer.
A Director, Development Program Management uses extensive program management knowledge and experience in the drug development industry to provide operational leadership, direction, and support to assigned development program(s) and/or portfolio(s).
ABOUT BRC: BRC is among the most comprehensive, effective, and fastest growing agencies in NYC serving homeless New Yorkers. With a $200 million budget and over 1700 employees, BRC has 29 programs throughout the New York City area that...
Overview How you move is why we're here. Now more than ever. Get back to what you need and love to do. The possibilities are endless... Now more than ever, our guiding principles are helping us in our search for exceptional...
Locations: Salamanca, NY Type:Tribal Salary Range:Salary Negotiable Open Period:8/8/2024 until filled Summary:The Director of Quality is responsible for managing risk, ensuring compliance, best practices and improving...
GENERAL PURPOSE: This position serves as a thought partner to the Vice President for Student Life (VPSL) in support of the University's new strategic plan where Student Life is a focal point. The incumbent provides support to the VPSL in...
Department/Unit: Medicine - Aids Program Work Shift: Day (United States of America) Salary range: $80,151.00 - $132,249.00 Associate Director Grant/Data Quality Location: 1 Clara Barton Drive Albany, NY...
Medical Education Systems Manager Job No: 496290 Department: GME OFFICE Local Title: Medical Education Systems Manager Budget Title: Senior Staff Associate Work Type: Full...
COMPANY Volastra Therapeutics, Inc. is a clinical stage oncology biotechnology company based in New York City focused on developing therapeutics that exploit chromosomal instability (CIN) as a unique vulnerability in cancer. Since its...